Evidence map›Paper›PMID 37503097›Full record

ArticlebioRxiv : the preprint server for biology2024

BuDDI:

Natalie R Davidson, Fan Zhang, Casey S Greene

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Natalie R DavidsonDepartment of Biomedical Informatics, University of Colorado Anschutz School of Medicine, Aurora, Colorado, United States of America · Funded by the Gordon and Betty Moore Foundation (GBMF 4552), NHGRI of the National Institutes of Health (K99HG012945), NCI of the National Institutes of Health (R01CA237170, R01CA243188, R01CA200854).ORCID 0000-0002-1745-8072
Fan ZhangDepartment of Medicine Rheumatology, University of Colorado Anschutz School of Medicine, Aurora, Colorado, United States of America; Department of Biomedical Informatics, University of Colorado Anschutz School of Medicine, Aurora, Colorado, United States of America · Funded by the Arthritis National Research Foundation Award, the PhRMA foundation, and the University of Colorado Translational Research Scholars Program Award.ORCID 0000-0002-6102-2970
Casey S GreeneDepartment of Biomedical Informatics, University of Colorado Anschutz School of Medicine, Aurora, Colorado, United States of America · Funded by the Gordon and Betty Moore Foundation (GBMF 4552), NCI of the National Institutes of Health (R01CA237170, R01CA243188, R01CA200854).ORCID 0000-0001-8713-9213

Funding

Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival: An Integrative ApproachR01CA243188 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI BANDERA, ELISA V, DOHERTY, JENNIFER ANNE · 2020 to 2025
$7.0M
Characterization of high-grade serous ovarian cancer subtypes via single-cell profilingR01CA237170 · NCI · UNIVERSITY OF PENNSYLVANIA · PI DOHERTY, JENNIFER A., GREENE, CASEY S · 2019 to 2024
$3.0M
Characterizing Molecular Subtypes of Ovarian Cancer in African-American WomenR01CA200854 · NCI · UNIVERSITY OF UTAH · PI DOHERTY, JENNIFER A., SCHILDKRAUT, JOELLEN M. · 2016 to 2021
$2.8M
Domain adaptation approaches to unify established and emerging sequencing technologiesR00HG012945 · NHGRI · UNIVERSITY OF COLORADO DENVER · PI Natalie Rose Davidson · 2024 to 2026
$747k
Domain adaptation approaches to unify established and emerging sequencing technologiesK99HG012945 · NHGRI · UNIVERSITY OF COLORADO DENVER · PI DAVIDSON, NATALIE ROSE · 2023 to 2024
$201k
NCI NIH HHS R01 CA200854NCI NIH HHS R01 CA237170NCI NIH HHS R01 CA243188NHGRI NIH HHS K99 HG012945NHGRI NIH HHS R00 HG012945
6 · The paper itself

Abstract

While single-cell experiments provide deep cellular resolution within a single sample, some single-cell experiments are inherently more challenging than bulk experiments due to dissociation difficulties, cost, or limited tissue availability. This creates a situation where we have deep cellular profiles of one sample or condition, and bulk profiles across multiple samples and conditions. To bridge this gap, we propose BuDDI (BUlk Deconvolution with Domain Invariance). BuDDI utilizes domain adaptation techniques to effectively integrate available corpora of case-control bulk and reference scRNA-seq observations to infer cell-type-specific perturbation effects. BuDDI achieves this by learning independent latent spaces within a single variational autoencoder (VAE) encompassing at least four sources of variability: 1) cell type proportion, 2) perturbation effect, 3) structured experimental variability, and 4) remaining variability. Since each latent space is encouraged to be independent, we simulate perturbation responses by independently composing each latent space to simulate cell-type-specific perturbation responses. We evaluated BuDDI's performance on simulated and real data with experimental designs of increasing complexity. We first validated that BuDDI could learn domain invariant latent spaces on data with matched samples across each source of variability. Then we validated that BuDDI could accurately predict cell-type-specific perturbation response when no single-cell perturbed profiles were used during training; instead, only bulk samples had both perturbed and non-perturbed observations. Finally, we validated BuDDI on predicting sex-specific differences, an experimental design where it is not possible to have matched samples. In each experiment, BuDDI outperformed all other comparative methods and baselines. As more reference atlases are completed, BuDDI provides a path to combine these resources with bulk-profiled treatment or disease signatures to study perturbations, sex differences, or other factors at single-cell resolution.

Identifiers

PMID37503097
PMCPMC10370205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.